A series of 33 patients with combined (injurious)
sleepwalking,
sleep terrors, and rapid eye movement (
REM) sleep behavior disorder (viz. "
parasomnia overlap disorder") was gathered over an 8-year period. Patients underwent clinical and polysomnographic evaluations. Mean age was 34 +/- 14 (SD) years; mean age of
parasomnia onset was 15 +/- 16 years (range 1-66); 70% (n = 23) were males. An idiopathic subgroup (n = 22) had a significantly earlier mean age of
parasomnia onset (9 +/- 7 years) than a symptomatic subgroup (n = 11) (27 +/- 23 years, p = 0.002), whose
parasomnia began with either of the following:
neurologic disorders, n = 6 [congenital
Mobius syndrome,
narcolepsy,
multiple sclerosis,
brain tumor (and treatment),
brain trauma, indeterminate disorder (exaggerated startle response/atypical
cataplexy)]; nocturnal
paroxysmal atrial fibrillation, n = 1;
posttraumatic stress disorder/major depression, n = 1; chronic
ethanol/
amphetamine abuse and withdrawal, n = 1; or mixed disorders (
schizophrenia,
brain trauma,
substance abuse), n = 2. The rate of DSM-III-R (Diagnostic and Statistical Manual, 3rd edition, revised) Axis 1
psychiatric disorders was not elevated; group scores on various psychometric tests were not elevated. Forty-five percent (n = 15) had previously received psychologic or psychiatric
therapy for their
parasomnia, without benefit. Treatment outcome was available for n = 20 patients; 90% (n = 18) had substantial
parasomnia control with bedtime
clonazepam (n = 13),
alprazolam and/or
carbamazepine (n = 4), or
self-hypnosis (n = 1). Thus, "
parasomnia overlap disorder" is a treatable condition that emerges in various clinical settings and can be understood within the context of current knowledge on
parasomnias and motor control/dyscontrol during sleep.